Thanks for the link dyode. That points to/reinforces MSB's product's efficacy.
Based on the link you provided I had a look around and this popped up from just a few days ago which adds further to the article you posted:
1. Inhibition of IL-11 signalling extends mammalian healthspan and lifespan
https://www.nature.com/articles/s41586-024-07701-9
2. A BBC article on the study above. A bit more dramatic, but the mice photo is intriguing.
https://www.bbc.com/news/articles/cv2gr3x3xkno
interleukin-11, page-8
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.040(3.16%) |
Mkt cap ! $1.490B | |||
| Open | High | Low | Value | Volume |
| $1.28 | $1.32 | $1.26 | $3.433M | 2.652M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39558 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 21776 | 3 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |